Company record · updated October 7, 2026
Chromacode Inc: 8 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs September 30, 2025 to June 30, 2026.
Source rails for this company: N-PORT fund mark (8).
Reported by 2 filers: T. Rowe Price Health Sciences Fund, Inc., T. Rowe Price Health Sciences Portfolio.
Read the step change before you read the trend
The mark for this company falls by a near-exact whole-number factor between two consecutive dates. That pattern is consistent with a share split, in which case it is not a fall in value at all.
- The mark moves from 4.84 on 2026-03-31 to 1.21 on 2026-06-30, a factor of 4.00.
This is an arithmetic observation, not a confirmed corporate action. The figures above and in the table are exactly as filed and are never adjusted here. Confirm the split against the company's own filings before reading either figure as a change in value.
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2026-06-30 | price per share | 1.21 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 757.46 / balance 626.0 [pp] | 000109926326009596 |
| 2026-06-30 | price per share | 1.21 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 33.88 / balance 28.0 [pp] | 000109926326009591 |
| 2026-03-31 | price per share | 4.8396 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 135.51 / balance 28.0 [pp] | 000109926326006593 |
| 2026-03-31 | price per share | 4.8398 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 3029.71 / balance 626.0 [pp] | 000109926326006598 |
| 2025-12-31 | price per share | 4.8396 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 135.51 / balance 28.0 [pp] | 000109926326002544 |
| 2025-12-31 | price per share | 4.8398 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 3029.71 / balance 626.0 [pp] | 000109926326002549 |
| 2025-09-30 | price per share | 4.8398 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 3029.71 / balance 626.0 [pp] | 000109926325003642 |
| 2025-09-30 | price per share | 4.8396 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 135.51 / balance 28.0 [pp] | 000109926325003637 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price.